NDC 68071-3871-01 - Allopurinol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3871
- Requested NDC
- 68071-3871-01
- Package NDCs from labels
- 68071-3871-1, 68071-3871-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2025-06-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Allopurinol - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2025-06-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3871-1 | Allopurinol | 100 in 1 BOTTLE | TABLET | 100 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allopurinol | ALLOPURINOL | Mylan Institutional Inc. | 994b3117-b83e-44d9-910c-1c3a26ef838e | 2025-07-18 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | NuCare Pharmaceuticals,Inc. | 3845c310-099b-8e11-e063-6394a90abd2f | 2025-06-23 | Warnings, Adverse reactions | ANDA204467 68071-3871-1 68071-3871 68071387101 197319 3845bbfe-6642-bf56-e063-6294a90ae3e2 3845c310-099b-8e11-e063-6394a90abd2f 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Zydus Lifesciences Limited | 9232f484-a5f6-4c63-b7f4-b510d2827159 | 2025-06-18 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | Advanced Rx of Tennessee, LLC | 36c1c908-1eed-ed2a-e063-6294a90a16f9 | 2025-05-29 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | American Health Packaging | f6f7642b-5046-47d6-b259-0c9f8aed3b34 | 2025-05-14 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | Preferred Pharmaceuticals Inc. | 09d34fab-250c-496a-93f5-c8d9f52a2276 | 2025-04-23 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Zydus Pharmaceuticals (USA) Inc. | 8b926e62-3a9c-424a-833a-8169e55a1f15 | 2025-04-07 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | NuCare Pharmaceuticals, Inc. | 2f27f578-f965-04c9-e063-6394a90a1ae2 | 2025-02-27 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Coupler LLC | 2d6ce57f-a9df-319e-e063-6394a90ac93f | 2025-02-05 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | NuCare Pharmaceuticals,Inc. | faf55184-6962-d49f-e053-6394a90a152e | 2025-02-04 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 5a1bfae2-116f-4ef9-bb7b-3b69ac74df03 | 2025-01-30 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Redpharm Drug | 0a22fa72-c363-4e96-e063-6394a90a48aa | 2025-01-23 | Warnings, Adverse reactions | ANDA204467 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Harman Finochem Limited | 0780dc78-d287-d5db-e063-6294a90aa1dd | 2025-01-09 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Preferred Pharmaceuticals Inc. | 7f9ad8db-ae68-4a0c-b858-1e727bc98130 | 2025-01-03 | Warnings, Adverse reactions | ANDA204467 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Advanced Rx Pharmacy of Tennessee, LLC | ec09fbcf-6e20-8438-e053-2a95a90a6376 | 2024-12-31 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | A-S Medication Solutions | 74dba96f-d388-40fe-8bca-53086d28c954 | 2024-12-24 | Warnings, Adverse reactions | ANDA204467 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | Bryant Ranch Prepack | 92253e70-0b0c-4a0c-9bd6-ccea91000819 | 2024-12-10 | Warnings, Adverse reactions | 197319 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | A-S Medication Solutions | d9a20bf5-15b9-4643-b829-40eacd4e849d | 2024-10-21 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| Allopurinol | ALLOPURINOL | A-S Medication Solutions | 869e09f7-fb72-4e15-8d4b-849e86ebc6fd | 2024-10-21 | Warnings, Adverse reactions | 197320 63CZ7GJN5I |
| ALLOPURINOL | ALLOPURINOL | Camber Pharmaceuticals, Inc. | 60750373-7146-455a-8d12-d0e32d2d4bc8 | 2024-10-17 | Warnings, Adverse reactions | 197319 197320 63CZ7GJN5I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.